CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a new type of coronary stent made from titanium oxynitride, which releases nitric oxide to enhance healing and reduce complications like re-narrowing and thrombosis. The aim is to improve treatment outcomes for patients with coronary artery disease.
Coronary artery disease is one of the leading causes of death worldwide.
Significant advances in treating coronary artery disease have been made over the last decade with the introduction of percutaneous coronary intervention (PCI). PCI involves the placement of stents within narrowed arteries relieving the symptoms of angina and in some cases increasing life expectancy.
The two major problems with currently available stent designs are restenosis and late thrombosis.
The former is more common in…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Rueil-Malmaison
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
United Kingdom, Brighton
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
